Richard Hopkins, the CEO of Zelda Therapeautics Ltd. (OTCQB: ZLDAF) an Australian-based bio-pharmaceutical company is focused on developing a range of cannabinoid-based medicines for the treatment of a variety of medical conditions. Richard joins the podcast to discuss the types of diseases and disorders Zelda is targeting.